David R. Gandara, MD, Professor of Medicine, Division of Hematology and Oncology, Director, Thoracic Oncology Program, Associate Director, Clinical Research, UC Davis Comprehensive Cancer Center, discusses the future of clinical trial designs.

The paradigm for drug development is changing in lung cancer, though new concepts and themes can be applied to all cancers. Gandara says drug development has been ineffective to date for cancer therapies as a whole.

There remains a need for new ways of thinking, new strategies, and new clinical trial designs to increase the likelihood of benefit for patients with specific genomic abnormalities.

Currently, less than 5% of cancer drugs actually make it to patients, Gandara says. This also needs to be improved.

View more from the 2014 Multidisciplinary Symposium in Thoracic Oncology

Conference

® Conference page includes a listing of all conferences covered by 

, including the ASCO, ESMO, SITC, EHA, ASH, and SABCS annual meetings, as well as the Chemotherapy Foundation Symposium and Miami Breast Cancer Conference, among many others. Conference coverage incorporates articles and interviews in written and video format.


Lung Cancer

The OncLive Lung Cancer condition center page is a comprehensive resource for clinical news and expert insights on non–small cell lung cancer, small cell lung cancer, mesothelioma, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in lung cancer.

Precision Medicine in Oncology®

The OncLive Precision Medicine in Oncology® condition center page is a comprehensive resource for clinical news and expert insights on precision-focused approaches in patients with cancer, with gene-targeted tyrosine kinase inhibitors and antibody-drug conjugates, checkpoint inhibitors, tumor-infiltrating lymphocyte therapy, and other tailored treatments. This page features news articles, interviews in written and video format, and podcasts that focus on updates and ongoing research with personalized therapies across solid and hematologic tumors.

Chicago Multidisciplinary Symposium in Thoracic Oncology

David R. Gandara, MD, from UC Davis Comprehensive Cancer Center, discusses the future of clinical trial designs.

Dr. Gandara Discusses the Future of Clinical Trial Designs